Dr. Jessica Erin Weinstein, MD

Dr. Weinstein practices at Spokane Eye Surgery Center in Spokane, Washington.

Dr. Weinstein's NPI, 1609212448, was assigned on May 20, 2013. Dr. Weinstein graduated from University of Miami, Lm Miller School of Medicine in 2013. Dr. Weinstein holds Washington license MD60727229.

Dr. Weinstein's primary practice is Spokane Eye Surgery Center, at 427 South Bernard, Suite 200, Spokane, WA 99204. The practice phone is (509) 456-8150.

Dr. Weinstein's primary practice is Spokane Eye Surgery Center in Spokane, Washington. Dr. Weinstein is also affiliated with MultiCare Deaconess Hospital. Dmand AI also links Dr. Weinstein to 1 more group practice or clinic and 1 medical group, each named with a free account. Dr. Weinstein's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weinstein practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Weinstein's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dmand AI has Dr. Weinstein's licenses on file in 3 states: Washington, Kentucky and North Carolina.

CMS data shows 33,784 Medicare services from Dr. Weinstein across 20 procedure codes in 2024, for 480 Medicare patients. Medicare paid $1,872,314 for them.

CMS counts 480 Medicare patients who saw Dr. Weinstein in 2024. The largest group is 65 to 74, with 194 patients. 70% of them have high blood pressure, and 63% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Weinstein's median patient age at 74, with 58% women.

In 2024, Dr. Weinstein wrote 499 Medicare Part D claims for 118 patients. 76% of them were for generic drugs. CMS names the drug for 457 of them, across 8 drugs with 11 or more claims each, at $11,610 in total drug cost. In 2023, CMS named 376 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Weinstein for performance year 2024, reported as part of a group. Dr. Weinstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 17 papers to Dr. Weinstein, published from 2011 to 2022. 2017 was the busiest year, with 2. The most frequent topics are Choroid, Disease Models, Animal and Uveitis. Dr. Weinstein has published most often in Invest Ophthalmol Vis Sci. Dr. Weinstein's most frequent co-authors are Kathryn Lynn Pepple, MD, PhD, Ramani Balu, MD and Joshua Levine.

CMS Open Payments shows 89 general payments to Dr. Weinstein from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 58% of the total. Apellis Pharmaceuticals, Inc. paid the most, $2,698.

Dr. Weinstein graduated from University of Miami, Lm Miller School of Medicine in 2013.